101 related articles for article (PubMed ID: 3199821)
1. Rapid metabolic inactivation of tipredane, a structurally novel topical steroid.
Lan SJ; Scanlan LM; Mitroka J; Weinstein SH; Lutsky BN; Free CA; Wojnar RJ; Millonig RC; Migdalof BH
J Steroid Biochem; 1988 Nov; 31(5):825-34. PubMed ID: 3199821
[TBL] [Abstract][Full Text] [Related]
2. Biotransformation of tipredane, a novel topical steroid, in mouse, rat, and human liver homogenates.
Lan SJ; Scanlan LM; Weinstein SH; Varma RK; Warrack BM; Unger SE; Porubcan MA; Migdalof BH
Drug Metab Dispos; 1989; 17(5):532-41. PubMed ID: 2573497
[TBL] [Abstract][Full Text] [Related]
3. In vitro biotransformation of glucocorticoids in liver and skin homogenate fraction from man, rat and hairless mouse.
Andersson P; Edsbäcker S; Ryrfeldt A; von Bahr C
J Steroid Biochem; 1982 Jun; 16(6):787-95. PubMed ID: 7109582
[TBL] [Abstract][Full Text] [Related]
4. Triamcinolone acetonide 21-oic acid methyl ester: a potent local antiinflammatory steroid without detectable systemic effects.
Gorsline J; Bradlow HL; Sherman MR
Endocrinology; 1985 Jan; 116(1):263-73. PubMed ID: 3855256
[TBL] [Abstract][Full Text] [Related]
5. Corticoids and human skin fibroblasts: intracellular specific binding in relation to growth inhibition.
Ponec M; De Kloet ER; Kempenaar JA
J Invest Dermatol; 1980 Oct; 75(4):293-6. PubMed ID: 7430694
[TBL] [Abstract][Full Text] [Related]
6. Development of glucocorticosteroids with enhanced ratio between topical and systemic effects.
Thalén A; Brattsand R; Andersson PH
Acta Derm Venereol Suppl (Stockh); 1989; 151():11-9; discussion 47-52. PubMed ID: 2624062
[TBL] [Abstract][Full Text] [Related]
7. The binding of topically applied glucocorticoids to rat skin.
Baker JR; Christian RA; Simpson P; White AM
Br J Dermatol; 1977 Feb; 96(2):171-8. PubMed ID: 843452
[TBL] [Abstract][Full Text] [Related]
8. Excretion and metabolism of tipredane, a novel glucocorticoid, in the rat, mouse, monkey, and human.
Cooper AE; Gray AJ; Collington J; Seddon H; Beattie I; Logan CJ
Drug Metab Dispos; 1996 Oct; 24(10):1071-80. PubMed ID: 8894507
[TBL] [Abstract][Full Text] [Related]
9. Aspects of pharmacodynamics and biotransformation of the glucocorticoid resocortol butyrate.
Coert A; Verheijen F; Horspool LJ; Mol JA
J Vet Pharmacol Ther; 2004 Oct; 27(5):309-15. PubMed ID: 15500568
[TBL] [Abstract][Full Text] [Related]
10. Topical betamethasone 17-valerate is an anticorticosteroid in the rat. 2. Anti-inflammatory and anti-lymphocyte activities.
Young JM; Wagner BM; Fisk RA
Br J Dermatol; 1978 Dec; 99(6):665-73. PubMed ID: 737129
[TBL] [Abstract][Full Text] [Related]
11. Interaction of rat liver glucocorticoid receptor with a newly synthesized antisteroid ZK98299.
Zakula Z; Moudgil VK
Biochim Biophys Acta; 1991 Apr; 1092(2):188-95. PubMed ID: 2018785
[TBL] [Abstract][Full Text] [Related]
12. Penetration of drugs through the skin.
Stoughton RB
Dermatologica; 1976; 152 Suppl 1():27-36. PubMed ID: 133842
[TBL] [Abstract][Full Text] [Related]
13. Objective determination of the bioavailability of dermocorticoids--influence of the formulation.
Poelman MC; Leveque JL; Le Gall F
Br J Dermatol; 1984 Jul; 111 Suppl 27():158-62. PubMed ID: 6743548
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics and metabolism of budesonide, a selective glucocorticoid.
Ryrfeldt A; Andersson P; Edsbäcker S; Tönnesson M; Davies D; Pauwels R
Eur J Respir Dis Suppl; 1982; 122():86-95. PubMed ID: 6958498
[TBL] [Abstract][Full Text] [Related]
15. Effect of structural alterations on the biotransformation rate of glucocorticosteroids in rat and human liver.
Andersson P; Lihné M; Thalén A; Ryrfeldt A
Xenobiotica; 1987 Jan; 17(1):35-44. PubMed ID: 3825176
[TBL] [Abstract][Full Text] [Related]
16. Androstene-17-thioketals. 2nd communication: pharmacological profiles of tipredane and (11 beta, 17 alpha)-17-(ethylthio)-9 alpha-fluoro-17-[2-(fluoroethyl)thio]-11 beta-hydroxy-androsta-1,4-dien-3-one, structurally novel 20-thiasteroids possessing potent and selective topical antiinflammatory activity.
Lutsky BN; Millonig RC; Wojnar RJ; Free CA; Devlin RG; Varma RK; Karanewsky DS
Arzneimittelforschung; 1986 Dec; 36(12):1787-95. PubMed ID: 3494459
[TBL] [Abstract][Full Text] [Related]
17. Distinction between binding of [3H]triamcinolone acetonide to a ligand binding domain on the glucocorticoid receptor complex in cytosol fractions of brain and liver from the rat with intact adrenals.
Yoneda Y; Han D; Ogita K; Watanabe A
Brain Res; 1995 Jul; 685(1-2):105-16. PubMed ID: 7583234
[TBL] [Abstract][Full Text] [Related]
18. Characteristics of binding of a new anti-inflammatory glucocorticoid, hydrocortisone 17-butyrate 21-propionate (HBP), to glucocorticoid receptors of rat liver.
Muramatsu M; Tanaka M; Otomo S; Aihara H; Kuriyama K
Jpn J Pharmacol; 1985 Feb; 37(2):143-50. PubMed ID: 3999470
[TBL] [Abstract][Full Text] [Related]
19. Enhancement of affinity to receptors in the esterified glucocorticoid, hydrocortisone 17-butyrate 21-propionate (HBP), in the rat liver.
Muramatsu M; Fujita A; Tanaka M; Ishii Y; Aihara H
Biochem Pharmacol; 1986 Jun; 35(12):1933-7. PubMed ID: 3718538
[TBL] [Abstract][Full Text] [Related]
20. Topical betamethasone 17-valerate is an anticorticosteroid in the rat. 1. Dermal atrophy.
Young JM; Yoxall BE; Wagner BM
Br J Dermatol; 1978 Dec; 99(6):655-63. PubMed ID: 737128
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
